Soluble CD14 and CD14 Variants, Other Inflammatory Markers, and Glucose Dysregulation in Older Adults: The Cardiovascular Health Study

OBJECTIVE: Experimental studies have implicated soluble (s)CD14, an effector of lipopolysaccharide-induced inflammation, in insulin resistance, but its role in human metabolic endotoxemia has not been studied. We evaluated sCD14 in relation to dysglycemia in older adults and how this compares to oth...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Care
Auteurs principaux: Shitole, Sanyog G., Biggs, Mary L., Reiner, Alexander P., Mukamal, Kenneth J., Djoussé, Luc, Ix, Joachim H., Barzilay, Joshua I., Tracy, Russell P., Siscovick, David, Kizer, Jorge R.
Format: Artigo
Langue:Inglês
Publié: American Diabetes Association 2019
Sujets:
Epidemiology/Health Services Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804612/
https://ncbi.nlm.nih.gov/pubmed/31471378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-0723
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires